Please login to the form below

Not currently logged in
Email:
Password:

Rezolsta

This page shows the latest Rezolsta news and features for those working in and with pharma, biotech and healthcare.

FDA approves BMS’ Evotaz for HIV

FDA approves BMS’ Evotaz for HIV

Cobicistat is already a crucial part of several HIV treatments, including Rezolsta/Prezcobix, which pairs the drug with Janssen's Prezista (darunavir), and Gilead's own combination therapy Stribild.

Latest news

  • EMA backs 15 new medicines for use in EU EMA backs 15 new medicines for use in EU

    Janssen's HIV treatment. Janssen looks set to expand its efforts in HIV treatment with a recommendation for Rezolsta, a combination of the company's Prezista (darunavir) and Gilead's boosting

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...

Infographics